Senate Bill 186

To: (1) Enable care-giving institutions to institute, and certain pharmacists to operate under, collaborative drug therapy management policies; (2) provide that prescribing practitioners and pharmacists may enter into collaborative drug therapy management agreements and operate under collaborative drug therapy management policies; (3) provide that collaborative drug therapy management agreements and policies may apply to patient populations; (4) require that written protocols and collaborative drug therapy care plans (A) be specific to the patient, patients or patient populations involved, (B) contain detailed direction concerning the actions pharmacists may perform for the patient population involved, (C) include the therapeutic class of drug or classes of drugs, or medical devices, to be managed by pharmacists, and (D) contain a definition of the patient population involved; (5) eliminate a reporting requirement concerning encounters within the scope of collaborative drug therapy management agreements; (6) impose a reporting requirement concerning changes made to drug therapies within the scope of collaborative drug therapy management agreements and policies; and (7) require the Commissioner of Consumer Protection to adopt regulations concerning collaborative drug therapy management policies.

In the Senate

• GL

  Sponsor

In the House of Representatives

l9n doesn't hold this bill's text yet.

In the Senate Feb 24 – Apr 18

1. Feb 24Introduced and sent to General Law Committee
2. Feb 25Heard in General Law Committee
3. Mar 15General Law Committee recommended it
4. Apr 13Sent to Appropriations Committee
5. Apr 18Appropriations Committee recommended it